Detalles de la búsqueda
1.
Chemoprevention in BRCA1 mutation carriers (CIBRAC): protocol for an open allocation crossover feasibility trial assessing mechanisms of chemoprevention with goserelin and anastrozole versus tamoxifen and acceptability of treatment.
BMJ Open
; 8(12): e023115, 2018 12 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-30580266
Resultados
1 -
1
de 1
1
Próxima >
>>